Shionogi Pharma Co., Ltd.

Shionogi Pharma was established as a new, wholly-owned subsidiary of Shionogi & Co.,Ltd. on October 1, 2018, which is in charge of manufacturing functions for the Shionogi group. We will contribute to the growth of the pharmaceutical industry in the world by developing contract manufacturing businesses. We are offering a high quality comprehensive service as CDMO (development & proposal type of CMO) for investigational drug and commercial production including API process development, formulation and packaging design, scale up, tech transfer, LCM, QC testing, pharmaceutical engineering and...